Blockade of HIV-1 infection of new world monkey cells occurs primarily at the stage of virus entry

Journal of Experimental Medicine

Volumn 196, Issue 4, 2002, Pages 431-445

  LaBonte, Jason A ^a   Babcock, Gregory J ^a,b   Patel, Trushar ^a   Sodroski, Joseph ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Human immunodeficiency virus; New World monkeys; Receptors; Species restrictions; Virus entry

Indexed keywords

CD4 ANTIGEN; CELL RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MARMOSET; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR BINDING; SQUIRREL MONKEY; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD4; CALLITHRIX; CELL LINE, TRANSFORMED; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RECEPTORS, CCR5; RECEPTORS, CXCR4; SAIMIRI; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0037136261     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020468     Document Type: Article

References (81)

1. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
2. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
3. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III
4. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques
5. Isolation of a new human retrovirus from West African patients with AIDS
6. The simian immunodeficiency viruses
7. NIH Conference. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic considerations
8. Serological identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III
9. The global impact of HIV/AIDS
10. Transmission of HTLV-III infection from human plasma to chimpanzees: An animal model for AIDS
11. Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzee
12. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy associated virus: A potential model for acquired immunodeficiency syndrome
13. The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: In vivo and in vitro correlations
14. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1
15. A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease
16. Chimpanzees in captivity: Humane handling and breeding with confines imposed by medical research and testing
17. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis
18. Conserved CXCR4 usage and enhanced replicative capacity of HIV-2/287, an isolate highly pathogenic in Macaca nemestrina
19. The 'V3′ domain is a determinant of simian immunodeficiency virus cell tropism
20. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
21. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
22. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
23. CC CKR5: A RANTES, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic HIV-1
24. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
25. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
26. Identification of a major co-receptor for primary isolates for HIV-1
27. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
28. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
29. HIV-1 entry co-factor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
30. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques
31. + T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques
32. Species-specific, post-entry barriers to primate immunodeficiency virus infection
33. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
34. Infection of rabbits with human immunodeficiency virus
35. Syphilis superinfection activates expression of human immunodeficiency virus 1 in latendy infected rabbits
36. Small animals are not susceptible to human immunodeficiency virus infection
37. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR5 co-receptor
38. Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits
39. CD4 and its role in infection of rabbit cell lines by human immunodeficiency virus type 1
40. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4
41. Murine CXCR-4 is a functional coreceptor for T-cell-tropic and dual-tropic strains of human immunodeficiency virus type 1
42. CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry
43. Chemokine receptors as HIV-1 co-receptors: Roles in viral entry, tropism, and disease
44. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection
45. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells
46. Recruitment of a protein complex containing Tat and cyclin T1 to Tar governs the specificity of HIV-1 Tat
47. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
48. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation
49. A block to human immunodeficiency virus type 1 assembly in murine cells
50. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection
51. HIV infection of primate lymphocytes and conservation of the CD4 receptor
52. Inoculation of New World primates with the human immunodeficiency virus
53. Animal models of human immunodeficiency virus infection
54. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1
55. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells
56. Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes
57. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1sequence subtypes A through G
58. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses
59. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line passaged human immunodeficiency virus type 1 isolates
60. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes
61. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line
62. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
63. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes
64. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
65. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
66. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
67. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule
68. The antigenic structure of the HIV gp120 envelope glycoprotein
69. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication
70. + T cells by a complex of the 100K viral protein and the T4 molecule
71. + T lymphocytes
72. Role of Vif in human immunodeficiency virus type 1 reverse transcription
73. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
74. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
75. Specific incorporation of cyclophilin A into HIV-1 virions
76. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
77. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811. A non-immunosuppressive cyclosporine analog
78. Functional association of cyclophilin A with HIV-1 virions
79. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies
80. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis
81. In vitro immortalization of marmoset cells with three subgroups of herpes virus saimiri